Volitional disorders: A proposal for DSM-V

References

• Abuzzahab FS, Brown VL. Control of Tourette's syndrome with topiramate. Am J Psychiatry 2001; 158: 968
   PubMed Web of Science ®Google Scholar
• Akiskal HS. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the ‘red sign,’ the ‘rule of three’ and other biographic signs of temperamental extravagance, activation and hypomania. J Affect Disord 2005; 84: 279–290
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Benazzi F. Optimizing the detection of bipolar II disorder in outpatient private practice: toward a systematization of clinical diagnostic wisdom. J Clin Psychiatry 2005; 66: 914–921
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th ed., text revision. Washington, DC: American Psychiatric Association.
   Google Scholar
• Andreasen NC. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophr Bull 2007; 33: 108–112
   PubMed Web of Science ®Google Scholar
• Arzeno Ferrao Y, Almeida VP, Bedin NR, Rosa R, D'Arrigo Busnello E. Impulsivity and compulsivity in patients with trichotillomania or skin picking compared with patients with obsessive-compulsive disorder. Comp Psychiatry 2006; 47: 282–288
   PubMed Web of Science ®Google Scholar
• Ashton AK. Olanzapine augmentation for trichotillomania. Am J Psychiatry 2001; 158: 1929–1930
   PubMed Web of Science ®Google Scholar
• Berrios GE. Obsessive-compulsive disorder: conceptual history in France during the 19th century. Comp Psychiatry 1989; 30: 283–295
   PubMed Web of Science ®Google Scholar
• Berrios GE, Gili M. Abulia and impulsiveness revisited: a conceptual history. Acta Psychiatr Scand 1995; 92: 161–167
   PubMed Web of Science ®Google Scholar
• Bienvenu OJ, Samuels JF, Riddle MA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48: 287–293
   PubMed Web of Science ®Google Scholar
• Black DW, Repertinger S, Gaffney GR, Gabel J. Family history and psychiatric comorbidity in persons with compulsive buying: preliminary findings. Am J Psychiatry 1998; 155: 960–3
   PubMed Web of Science ®Google Scholar
• Black DW. Compulsive buying disorder: definition, assessment, epidemiology and clinical management. CNS Drugs 2001; 15: 17–2
   PubMed Web of Science ®Google Scholar
• Black DW, Monahan PO, Temkit M, Shaw M. A family study of pathological gambling. Psychiatry Res 2006; 141: 295–303
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002; 14: 9–15
   PubMedGoogle Scholar
• Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000; 32(Suppl i–v)1–112
   Google Scholar
• Burt VK. Impulse-control disorder not elsewhere classified. Comprehensive Textbook of Psychiatry6th edition, HI Kaplan, BJ Sadock. Williams and Wilkins, Baltimore 1995
   Google Scholar
• Carrion VG. Naltrexone for the treatment of trichotillomania: a case report. J Clin Psychopharmacol 1995; 15: 444–445
   PubMed Web of Science ®Google Scholar
• Carter WG, 3rd, Shillcutt SD. Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation. J Clin Psychiatry 2006; 67: 1311
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Ritchie GF, Marsh WL, Rapoport JL. DSM-IV stereotypic movement disorder: persistence of stereotypies of infancy in intellectually normal adolescents and adults. J Clin Psychiatry 1997; 57: 116–122
   Web of Science ®Google Scholar
• Christensen GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 1991; 148: 365–370
   PubMed Web of Science ®Google Scholar
• Christensen RC. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking. Can J Psychiatry 2004; 49: 788–789
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Schmidt CA, Samuels JF, Nestadt G. Lifetime and 1-Month Prevalence Rates of Intermittent Explosive Disorder in a Community Sample. J Clin Psychiatry 2004; 65: 820–824
   PubMed Web of Science ®Google Scholar
• Coleman E. Compulsive sexual behavior. New concepts and treatments. J Psychol Hum Sexual 1991; 4: 37–52
   Google Scholar
• Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988; 45: 111–119
   PubMed Web of Science ®Google Scholar
• Dannon PN. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol 2003; 26: 1–4
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Gonopolski Y JR, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. J Clin Neuropharmacol 2005a; 28: 6–10
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Musin E JR, Gonopolski Y, Kotler M. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol 2005b; 25: 593–596
   PubMed Web of Science ®Google Scholar
• Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review. Clin Pract Epidemiol Ment Health 2005; 1: 21
   PubMedGoogle Scholar
• Denys D, van Megen HJ, Westenberg HG. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. J Psychopharmacol 2003; 17: 127–129
   PubMed Web of Science ®Google Scholar
• du Toit PL, van Kradenburg J, Niehaus DJ, Stein DJ. Characteristics and phenomenology of hair-pulling: an exploration of subtypes. Comp Psychiatry 2001; 42: 247–256
   PubMed Web of Science ®Google Scholar
• Epperson CN, Fasula D, Wasylink S, Price LH, McDougle CJ. Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. J Child Adolesc Psychopharmacol 1999; 9: 43–49
   PubMed Web of Science ®Google Scholar
• Erickson CK, Wilcox RE. Please, Not ‘Addiction’ in DSM-V. Am J Psychiatry 2006; 163: 2015–2016
   PubMed Web of Science ®Google Scholar
• Esquirol JE. Des maladies mentales considérée sous les rapports médical, hygienique et médico-legal. Paris, Bailliere. 1838
   Google Scholar
• Fainsinger RL, Thai V, Frank G, Fergusson J. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 2014
   PubMedGoogle Scholar
• First, MB. DSM-V research planning activities: obsessive-compulsive spectrum disorders conference. http://dsm5.org/conference10.cfm. Assessed on 6 December 2007.
   Google Scholar
• Fong TW, De La Garza R 2nd, Newton TF. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol 2005; 25: 512–4
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Mendlowicz MV, Mussi TC, Marques C, Versiani M. The man with the purple nostrils: a case of rhinotrichotillomania secondary to body dysmorphic disorder. Acta Psychiatr Scand 2002; 106: 464–466
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M. An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opin Pharmacother 2007; 8: 563–583
   PubMed Web of Science ®Google Scholar
• Gabriel A. A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry 2001; 46: 285–6
   PubMed Web of Science ®Google Scholar
• Gadde KM, Ryan Wagner H, 2nd, Connor KM, Foust MS. Escitalopram treatment of trichtillomania. Int Clin Psychopharmacol. 2007; 22: 39–42
   PubMed Web of Science ®Google Scholar
• Garnis-Jones S, Collins S, Rosenthal D. Treatment of self-mutilation with olanzapine. J Cutan Med Surg 2000; 4: 161–163
   PubMedGoogle Scholar
• Georget EJ. De la folie. Considération sur Cette Maladie. Paris, Crevot. 1820
   Google Scholar
• Gerstein DR, Volberg RA, Toce MT, Harwood H, Palmer A, Johnson R, Larison C, Chuchro L, Buie T, Engelman L, Hill MA. Gambling impact and behavior study. Report to the National Gambling Impact Study Commission. National Opinion Research Center at the University of Chicago, Chicago 1999
   Google Scholar
• Ghaziuddin M, Tsai LY, Ghaziuddin N. Brief report: haloperidol treatment of trichotillomania in a boy with autism and mental retardation. J Autism Dev Disord 1991; 21: 365–371
   PubMed Web of Science ®Google Scholar
• Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activiy in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 2007; 21: 501–6
   PubMed Web of Science ®Google Scholar
• Goldman MJ. Kleptomania: making sense of the nonsensical. Am J Psychiatry 1991; 148: 986–996
   PubMed Web of Science ®Google Scholar
• Goldner EM, Geller J, Birmingham CL, Remick RA. Comparison of shoplifting behaviours in patients with eating disorders, psychiatric control subjects, and undergraduate control subjects. Can J Psychiatry 2000; 45: 471–475
   PubMed Web of Science ®Google Scholar
• Goodman A. Sexual addiction: An integrated approach. International Universities Press, Inc, Madison, CT 1998
   Google Scholar
• Gupta MA, Gupta AK. Olanzapine is effective in the management of some self-induced dermatoses: three case reports. Cutis 2000; 66: 143–146
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 2002; 63: 349–356
   PubMed Web of Science ®Google Scholar
• Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol 2006; 21: 203–209
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 2003; 18: 243–249
   PubMed Web of Science ®Google Scholar
• Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006; 163: 303–312
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Potenza MN. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry 2007; 15: 80–85
   PubMed Web of Science ®Google Scholar
• Greenberg H. Impulse-control disorders not elsewhere classfied. Comprehensive Textbook of Psychiatry8th edition, HI Kaplan, BJ Sadock. Williams and Wilkins, Baltimore 2005
   Google Scholar
• Hemmings SM, Kinnear CJ, Lochner C, Seedat S, Corfield VA, Moolman-Smook JC, Stein DJ. Genetic correlates in trichotillomania–A case-control association study in the South African Caucasian population. Isr J Psychiatry Relat Sci 2006; 43: 93–101
   PubMed Web of Science ®Google Scholar
• Himle A, Bordnick PS, Thyer BA. A Comparison of Trichotillomania and obsessive-compulsive disorder. Journal of Psychopathology and Behavioral Assessment 1995; 17: 251–260
   Web of Science ®Google Scholar
• Hollander E, Allen A. Is compulsive buying a real disorder, and is it really compulsive?. Am J Psychiatry 2006; 163: 1670–1672
   PubMed Web of Science ®Google Scholar
• Hollander E, Bell'Osso B. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. Int Clin Psychopharmacol 2006; 21: 189–191
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000; 47: 813–817
   PubMed Web of Science ®Google Scholar
• Hollander E, Kaplan A, Stahl SM. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 2003a; 4: 30–34
   PubMed Web of Science ®Google Scholar
• Hollander E, Tracy KA, Swann AC, et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003b; 28: 1186–1197
   PubMed Web of Science ®Google Scholar
• Insel TR, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry 1983; 140: 1219–1220
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003; 361: 1677–1685
   PubMed Web of Science ®Google Scholar
• Kant R, Chalansani R, Chengappa KN, Dieringer MF. The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2004; 14: 57–63
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?. Sex Abuse 2003; 15: 307–321
   PubMedGoogle Scholar
• Kafka MP, Prentky R. A comparative study of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1992; 53: 345–350
   PubMed Web of Science ®Google Scholar
• Kafka MP, Prentky RA. Preliminary observations of DSM-III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders. J Clin Psychiatry 1994; 55: 481–487
   PubMed Web of Science ®Google Scholar
• Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160: 4–12
   PubMed Web of Science ®Google Scholar
• Keuler DJ, Altemus M, Michelson D, Greenberg B, Murphy DL. Behavioral effects of naloxone infusion in obsessive-compulsive disorder. Biol Psychiatry 1996; 40: 154–156
   PubMed Web of Science ®Google Scholar
• Khazaal Y, Zullino DF. Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry 2006; 6: 22
   PubMed Web of Science ®Google Scholar
• Khazaal Y, Krenz S, Benmebarek M, Zullino DF. Worsening of obsessive-compulsive symptoms under methadone tapering. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1350–1352
   PubMed Web of Science ®Google Scholar
• Khouzan HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry 2002; 65: 261–270
   PubMed Web of Science ®Google Scholar
• Kilts CD, Gross RE, Ely TD, Drexler KP. The neural correlates of cue-induced craving in cocaine-dependent women. Am J Psychiatry 2004; 161: 233–41
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–921
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 501–507
   PubMed Web of Science ®Google Scholar
• King RA, Scahill L, Vitulano LA, Schwab-Stone M, Tercyak KPJr, Riddle MA. Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. J Am Aca Child Adolesc Psychiatry 1995; 34: 1451–9
   PubMed Web of Science ®Google Scholar
• Koran LM, Chuong HW, Bullock KD, Smith SC. Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation. J Clin Psychiatry 2003; 64: 793–8
   PubMed Web of Science ®Google Scholar
• Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M. Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2005; 66: 353–359
   PubMed Web of Science ®Google Scholar
• Lejoyeux M, Feuche N, Loi S, Solomon J, Ades J. Study of impulse-control disorders among alcohol-dependent patients. J Clin Psychiatry 1999; 60: 302–5
   PubMed Web of Science ®Google Scholar
• Lenane MC, Swedo SE, Rapoport JL, Leonard H, Sceery W, Guroff JJ. Rates of Obsessive Compulsive Disorder in first degree relatives of patients with trichotillomania: a research note. J Child Psychol Psychiatry 1992; 33: 925–933
   PubMed Web of Science ®Google Scholar
• Leonard HL, Lenane MC, Swedo SE, Rettew DC, Rapoport JL. A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry 1991; 48: 821–827
   PubMed Web of Science ®Google Scholar
• Leckman JF, Rauch SL, Mataix-Cols D. Symptom dimensions in obsessive-compulsive disorder: implications for the DSM-V. CNS Spectr 2007; 12: 376–400
   PubMed Web of Science ®Google Scholar
• Levin T. Schizophrenia should be renamed to help educate patients and the public. Int J Soc Psychiatry 2006; 52: 324–331
   PubMed Web of Science ®Google Scholar
• Lobo DS, Kennedy JL. The genetics of gambling and behavioral additions. CNS Spectr 2006; 11: 931–939
   PubMed Web of Science ®Google Scholar
• Lochner C, Simeon D, Niehaus DJ, Stein DJ. Trichotillomania and skin-picking: a phenomenological comparison. Depress Anxiety 2002; 15: 83–86
   PubMed Web of Science ®Google Scholar
• Lochner C, Hemmings SM, Kinnear CJ, Niehaus DJ, Nel DG, Corfield VA. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Comp Psychiatry 2005; 46: 14–19
   PubMed Web of Science ®Google Scholar
• Lochner C, Seedat S, Niehaus DJ, Stein DJ. Topiramate in the treatment of trichotillomania: an open-label pilot study. Int Clin Psychopharmacol 2006; 21: 255–259
   PubMed Web of Science ®Google Scholar
• Loew TH, Nickel MK, Muehlbacher M, et al. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006; 26: 61–66
   PubMed Web of Science ®Google Scholar
• Longoria J, Brown ES, Perantie DC, Bobadilla L, Nejtek VA. Quetiapine for alcohol use and craving in bipolar disorder. J Clin Psychopharmacol 2004; 24: 101–102
   PubMed Web of Science ®Google Scholar
• Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 2000; 57: 649–54
   PubMed Web of Science ®Google Scholar
• Marazziti D, Dell'Osso B. Topiramate plus citalopram in the treatment of compulsive-impulsive sexual behaviors. Clin Pract Epidemiol Ment Health 2006; 2: 9
   PubMedGoogle Scholar
• Martin G, Bergen HA, Richardson AS, Roeger L, Allison S. Correlates of firesetting in a community sample of young adolescents. Aust NZ J Psychiatry 2004; 38: 148–154
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. A controlled trial of lithium augmentation in fluvoxamine-refractory bsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol 1991; 11: 175–184
   PubMed Web of Science ®Google Scholar
• McElroy SL, Pope HGJr, Keck PE, Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorder?. Compr Psychiatry 1996; 37: 229–240
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. Topiramate Binge Eating Disorder Research Group. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 2007; 61: 1039–1048
   PubMed Web of Science ®Google Scholar
• McIntyre RS, McElroy SL, Konarski JZ, Soczynska JK, Wilkins K, Kennedy SH. Problem gambling in bipolar disorder: Results from the Canadian Community Health Survey. J Affect Disord 2007; 102: 27–34
   PubMed Web of Science ®Google Scholar
• Miller SC. Language and addiction. Am J Psychiatry 2006; 163: 2005
   PubMed Web of Science ®Google Scholar
• Mitchell P. Internet addiction: genuine diagnosis or not?. Lancet 2000; 355: 632
   PubMed Web of Science ®Google Scholar
• Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001; 158: 1783–1793
   PubMed Web of Science ®Google Scholar
• Mullen PE, Pathe M. Stalking and the pathologies of love. Aust NZ J Psychiatry 1994; 28: 469–477
   PubMed Web of Science ®Google Scholar
• Nickel MK, Nickel C, Mitterlehner FO, et al. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 2004; 65: 1515–1519
   PubMed Web of Science ®Google Scholar
• Nickel C, Tritt K, Muehlbacher M, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 2005; 38: 295–300
   PubMed Web of Science ®Google Scholar
• Ninan PT, McElroy SL, Kane CP, Knight BT, Casuto LS, Rose SE, Marsteller FA, Nemeroff CB. Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. J Clin Psychopharmacol 2000; 20: 362–6
   PubMed Web of Science ®Google Scholar
• O'Brien CP, Volkow N, Li TK. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 764–765
   PubMed Web of Science ®Google Scholar
• O'Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, Keuthen NJ, Savage CR, Manzo PA, Caviness VS, Jenike MA. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997; 42: 39–45
   PubMed Web of Science ®Google Scholar
• O'Sullivan RL, Christenson GA, Stein DJ. Pharmacotherapy of trichotillomania. Trichotillomania, DJ Stein, GA Christianson, E Hollander. American Psychiatric Press, Washington, DC 1999; 93–124
   Google Scholar
• Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002; 63: 559–564
   PubMed Web of Science ®Google Scholar
• Pathak S, Danielyan A, Kowatch RA. Successful treatment of trichotillomania with olanzapine augmentation in an adolescent. J Child Adolesc Psychopharmacol 2004; 14: 153–154
   PubMed Web of Science ®Google Scholar
• Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005; 66: 564–74
   PubMed Web of Science ®Google Scholar
• Pinel P. Traité Médico-Philosophique de la Aliénation Mentale2nd edition. Paris, Brosson. 1809
   Google Scholar
• Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, O'Malley SS. Gender-related difference in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 2001; 158: 1500–5
   PubMed Web of Science ®Google Scholar
• Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, Skudlarski P, Gore JC. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003a; 160: 1990–4
   PubMed Web of Science ®Google Scholar
• Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, Rounsaville BJ, Gore JC, Wexler BE. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003b; 60: 828–36
   PubMed Web of Science ®Google Scholar
• Potenza MN, Xian H, Shah K, Scherrer JF, Eisen SA. Shared genetic contributions to pathological gambling and majo depression in men. Arch Gen Psychiatry 2005; 62: 1015–21
   PubMed Web of Science ®Google Scholar
• Potenza MN. Should addictive disorders include non-substance-related conditions?. Addiction 2006; 101(Suppl 1)142–151
   PubMed Web of Science ®Google Scholar
• Potenza MN, Wasylink S, Epperson CN, McDougle CJ. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. Am J Psychiatry 1998; 155: 1299–1300
   PubMed Web of Science ®Google Scholar
• Raymond NC, Grant JE, Kim SW, Coleman E. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol 2002; 17: 201–205
   PubMed Web of Science ®Google Scholar
• Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8: 147–8
   PubMed Web of Science ®Google Scholar
• Risinger RC, Salmeron BJ, Ross TJ, Amen SL, Sanfilipo M, Hoffmann RG, Bloom AS, Garavan H, Stein EA. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 2005; 26: 1097–108
   PubMed Web of Science ®Google Scholar
• Ross HE. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 1993; 88: 209–218
   PubMed Web of Science ®Google Scholar
• Rubio G, Jimenez-Arriero MA, Martinez-Gras I, Manzanares J, Palomo T. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder. J Clin Psychopharmacol 2006; 26: 341–344
   PubMed Web of Science ®Google Scholar
• Ryback RS. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry 2004; 65: 982–986
   PubMed Web of Science ®Google Scholar
• Saiz-Ruiz J, Blanco C, Ibanez A, et al. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005; 66: 28–33
   PubMed Web of Science ®Google Scholar
• Sato M. Renaming schizophrenia: a Japanese perspective. World Psychiatry 2006; 5: 53–55
   PubMed Web of Science ®Google Scholar
• Schaffer SD, Zimmerman ML. The sexual addict: a challenge for the primary care provider. Nurse Pract 1990; 15: 25–33
   PubMedGoogle Scholar
• Schlosser S, Black DW, Blum N, Goldstein RB. The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. Ann Clin Psychiatry 1994; 6: 147–152
   PubMedGoogle Scholar
• Seedat S, Kesler S, Niehaus DJ, Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 2000; 11: 185–186
   PubMed Web of Science ®Google Scholar
• Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics 2002; 43: 429–430
   PubMed Web of Science ®Google Scholar
• Shapira NA, Keck PE, Jr, Goldsmith TD, McConville BJ, Eis M, McElroy SL. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder. Depress Anxiety 1997a; 6: 170–173
   PubMedGoogle Scholar
• Shapira NA, McConville BJ, Pagnucco ML, Norman AB, Keck PE, Jr. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome. J Clin Psychiatry 1997b; 58: 174–175
   PubMed Web of Science ®Google Scholar
• Shapira NA, Lessig MC, Murphy TK, Driscoll DJ, Goodman WK. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome. Int J Neuropsychopharmacol 2002; 5: 141–145
   PubMed Web of Science ®Google Scholar
• Shiah IS, Chao CY, Mao WC, Chuang YJ. Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. Int Clin Psychopharmacol 2006; 21: 241–243
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006; 21: 2214–2217
   PubMed Web of Science ®Google Scholar
• Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993; 50: 377–385
   PubMed Web of Science ®Google Scholar
• Spunt B. Pathological gambling and substance misuse. Subst Use Misuse 2002; 37: 1299–304
   PubMed Web of Science ®Google Scholar
• Srivastava RK, Sharma S, Tiwari N, Saluja B. Olanzapine augmentation of fluoxetine in trichotillomania: two cases. Aust NZ J Psychiatry 2005; 39: 112–113
   PubMed Web of Science ®Google Scholar
• Stanley MA, Swann AC, Bowers TC, Davis ML, Taylor DJ. A comparison of clinical features in trichotillomania and obsessive-compulsive disorder. Behav Res Ther 1992; 30: 39–44
   PubMed Web of Science ®Google Scholar
• Stanley MA, Cohen LJ. Trichotillomania and obsessive-compulsive disorder. Trichotillomania, DJ Stein, GA Christenson, E Hollander. American Psychiatric Press, Washington, DC 1999; 225–261
   Google Scholar
• Stekel, W. 1925. Peculiarities of behavior: Wandering mania, dipsomania, cleptomania, Pyromania and allied impulsive acts. van Teslaar JS, translator/editor. London: William and Norgate.
   Google Scholar
• Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 1992; 53: 123–126
   PubMed Web of Science ®Google Scholar
• Stein DJ, Black DW, Shapira NA, Spitzer RL. Hypersexual disorder and preoccupation with internet pornography. Am J Psychiatry 2001; 158: 1590–1594
   PubMed Web of Science ®Google Scholar
• Stein DJ, van Heerden B, Hugo C, van Kradenburg J, Warwick J, Zungu-Dirwayi N, Seedat S. Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 885–890
   PubMed Web of Science ®Google Scholar
• Stein DJ, Chamberlain SR, Fineberg N. An A-B-C model of habit disorders: hair-pulling, skin-picking, and other stereotypic conditions. CNS Spectr 2006; 11: 824–827
   PubMed Web of Science ®Google Scholar
• Stewart RS, Nejtek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 2003; 64: 49–52
   PubMed Web of Science ®Google Scholar
• Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 1995; 152: 1192–6
   PubMed Web of Science ®Google Scholar
• Streltzer J, Sullivan CR, Johnson B. Addiction versus dependence in pain management. Am J Psychiatry 2006; 163: 2016
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989; 321: 497–501
   PubMed Web of Science ®Google Scholar
• Tavares, H, Gentil, V. Pathological gambling and obsessive-compulsive disorder: towards a spectrum of disorders of volition. Rev Bras Psiquiatr, 29:107–117.
   PubMed Web of Science ®Google Scholar
• Tukel R, Keser V, Karali NT, Olgun TO, Calikusu C. Comparison of clinical characteristics in trichotillomania and obsessive-compulsive disorder. J Anxiety Disord 2001; 15: 433–41
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999; 56: 219–226
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Patterson B, Bennett M. Topiramate augmentation in treatment-resistant obsessive compulsive disorder: a retrospective, open-label case series. Depress Anxiety 2006; 23: 1–5
   PubMed Web of Science ®Google Scholar
• Vulink NC, Denys D, Westenberg HG. Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. J Clin Psychiatry 2005; 66: 228–230
   PubMed Web of Science ®Google Scholar
• Wells S, Graham K, West P. Alcohol-related aggression in the general population. J Stud Alcohol 2000; 61: 626–632
   PubMed Web of Science ®Google Scholar
• Welte J, Barnes G, Wieczorek Q, Tidwell MC, Parker J., Jr. Alcohol and gambling pathology among U.S. adults: prevalence, demographic patters and comobidity. J Studies Alcohol 2001; 62: 706–712
   PubMed Web of Science ®Google Scholar